US Medical Affairs Lead, Belantamab Mafodotin

Job Purpose

The US Medical Affairs Leader is the single point of medical accountability for a medicine or medicine(s) and leads the development and execution of US Medical Affairs strategy and plans. This role is critical to the overall success of the medicine and in ensuring patients benefit from our scientific advancements.  This leader is responsible for ensuring strategic alignment with US Commercial, Global Medical, and the overall US Medical matrix. Position will lead, directly and indirectly, a Medical Matrix Team (MMT) responsible for developing and executing US Medical Affairs Strategic and tactical plans.   

Key responsibilities

• Accountable for developing US medical strategy, ensuring medical strategy and plans are aligned with commercial asset strategy where appropriate; Co-Leads the US Integrated Brand Commercialization Team in partnership with US Brand Marketing and Payer Leads
• Leads the development and execution of the US Medical Affairs Plan; Leads the cross-functional Medical Matrix Team to tailor/ adapt global asset strategy for US specific customer needs and environment.  Provides strategic oversight of US Tactical Plans.
• Represents the US medical affairs perspective at the Global Medical Team and Medicine Commercialization Team meetings, bringing a strong US view on medical strategy and US customer needs as input to global strategy; Cocreates Global Medical Strategy to ensure US needs and issues are addressed
• Gathers and communicates medical insights from internal and external US stakeholders (Investigators/HCP’s, Patients, Payors and Regulators) to shape product development decisions, Global Medical Affairs Plans, and integrated evidence strategy and plan.
• Working with Therapeutic Area Head, ensures strategic alignment of asset positioning and evidence planning with the overall therapeutic portfolio and disease area strategies; Serves as key member of US Medical Oncology Leadership team.
• Leads appropriate medical engagement between GSK and external communities to advance scientific and medical understanding including the appropriate development and use of our medicines, the management of disease, and patient care.
• Provides guidance to field medical teams on ISS/SCS areas of interest aligned to US medical strategy; advocate for aligned US ISS/SCS concepts at Global Medical Review Committee meetings
• Working in concert with the US Value Evidence and Outcomes team, identifies US evidence gaps and drives local evidence generation planning
• Manages budget and spend targets for the disease area and its assets in the US
• Applies sound medical governance for all activities and is accountable for medical governance oversight and sign off for asset

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• PharmD, PhD, nursing, allied health professional (eg, epidemiology) or other advanced scientific degree.
• Oncology Medical Affairs Experience
• 5 or more years working with medical affairs in pharmaceutical role

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

• Medical Degree
• Multiple myeloma knowledge and experience (preferred)
• Broad drug development experience with robust knowledge of GCP regulatory/ market access and reimbursement requirements.
• Significant experience in Medical Affairs and life cycle management preferred, including launch support requirements.
• Robust understanding of promotional codes/ regulations; previous involvement in review and approval processes.
• Highly developed leadership, networking, communication and influencing skills to work effectively in a complex matrix environment.
• Demonstrated ability to build strong internal and external networks.

​

Please visit  GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and ge